Prevalence of FGFR2b expression, characteristics, treatment and outcomes in patients with metastatic gastric and gastroesophageal junction adenocarcinoma in Germany.

14. September 2026

L.J. Haug, K. Ringwald, A. Binninger, L. Tzala, K. Isse, R. Winkelmann, P. Stenzel, E. von der Heyde, C. Müller, D. Semsek, A. Servatius, I. Majer, H. Honeycutt, F. Lordick, P.J. Wild, M. Jaenicke, K.M. Potthoff

Annals of Oncology, 37S195. DOI:10.1016/j.annonc.2026.05.566

Abstract Poster